Fabio Magrini

Title: The Innovations of Fabio Magrini

Introduction

Fabio Magrini is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly through his work on engineered antibodies. His innovative approach has led to advancements in treatments for various autoimmune conditions.

Latest Patents

Magrini holds a patent for IL-21 antibodies and methods of making or using the antibodies. This invention relates to engineered, humanized antibodies that exhibit high binding affinity for and neutralize human IL-21. The methods outlined in the patent are aimed at treating conditions where antagonism or neutralization of IL-21 is necessary. This includes autoimmune conditions, as well as compositions and methods for recombinantly producing the antibodies, and pharmaceutical compositions that incorporate these antibodies. He has 1 patent to his name.

Career Highlights

Throughout his career, Fabio Magrini has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Eli Lilly and Company and Medimmune Limited. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.

Collaborations

Magrini has collaborated with several professionals in his field, including Julian Davies and Andrea Paula Martin. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Fabio Magrini's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in the development of IL-21 antibodies, highlight the importance of research in addressing complex medical conditions. His career reflects a commitment to advancing healthcare through scientific discovery.